Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells

Endocrinology

Volumn 138, Issue 6, 1997, Pages 2219-2226

  Lowe Jr , William L ^a   Fu, Ronggen ^a   Banko, Michelle ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GROWTH FACTOR; HYBRID PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; GENETIC TRANSCRIPTION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 8244221018     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.6.5159     Document Type: Article

References (61)

1. Seuwen K, Pouyssegur J 1992 G protein-controlled signal transduction pathways and the regulation of cell proliferation. Adv Cancer Res 58:75-94
2. Cho-Chung YS 1992 Suppression of malignancy targeting cyclic AMP signal transducing proteins. Biochem Soc Trans 20:425-430
3. Starzec AB, Spanakis E, Nehme A, Salle V, Veber N, Mainguene C, Planchon P, Valette A, Prevost G, Israel L 1994 Proliferative responses of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesis. J Cell Physiol 161:31-38
4. Kung W, Roos W, Eppenberger U 1983 Growth stimulation of human breast cancer MCF-7 cells by dibutyryl cAMP. Cell Biol Int Rep 7:345-351
5. Sheffield LG, Welsch CW 1985 Cholera-toxin-enhanced growth of human breast cancer cell lines in vitro and in vivo: interaction with estrogen. Int J Cancer 36:479-483
6. Revillion F, Vandewalle B, Lassalle B, Lefebvre J 1992 cAMP effect on extracellular matrix synthesis in human breast cancer cells. Cell Prolif 25:633-642
7. Drees M, Zimmermann R, Eisenbrand G 1993 3′,5′-Cyclic nucleotide phosphodiesterase in tumor cells as potential targets for tumor growth inhibition. Cancer Res 53:3058-3061
8. 1/S transition in mammary carcinoma cells (MCF-7). Endocrinology 136:2513-2520
9. Planchon P, Veber N, Magnien V, Prevost G, Starzec AB, Israel L 1995 Evidence for separate mechanisms of antiproliferative action of indomethacin and prostaglandin on MCF-7 breast cancer cells. Life Sci 57:1233-1240
10. Cook SJ, McCormick F 1993 Inhibition of Ras-dependent activation of Raf. Science 262:1069-1072
11. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW 1993 Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069
12. Sevetson BR, Kong X, Lawrence Jr JC 1993 Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 90:10305-10309
13. Graves LM, Bornfeldt KE, Raines EW, Potts BC, MacDonald SG, Ross R, Krebs EG 1993 Protein kinase A antagonizes platelet-derived growth factor-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA 90:10300-10304
14. ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J 12:4211-4220
15. ras-mitogen activated protein kinase pathway in fibroblasts. J Biol Chem 269:3534-3538
16. Siddhanti SR, Hartle II JE, Quarles LD 1995 Forskolin inhibits protein kinase C-induced mitogen-activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology 136:4834-4841
17. Davis RJ 1993 The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14356
18. Seger R, Krebs EG 1995 The MAPK signaling cascade. FASEB J 9:726-735
19. Treisman R 1994 Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev 4:96-101
20. mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90:8319-8323
21. Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouyssegur J 1995 Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10:1895-1904
22. Dickson RB, Lippman ME 1995 Growth factors in breast cancer. Endocr Rev 16:559-589
23. Yee D 1994 The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res Treat 32:85-95
24. Karey KP, Sirbasku DA 1988 Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res 48:4083-4092
25. Arteaga CL, Osborne CK 1989 Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 49:6237-6241
26. Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D 1993 Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 breast cancer cells. J Cell Physiol 157:229-236
27. Jammes H, Peyrat J-P, Ban E, Vilain M-O, Haour F, Dijiane J, and Bonneterre J 1992 Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis. Br J Cancer 66:248-253
28. Normanno N, Ciardiello F, Brandt R, Salomon DS 1994 Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 29:11-27
29. Toi M, Tominaga T, Osaki A, Toge T 1994 Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical and an immunocytochemical study. Breast Cancer Res Treat 29:51-58
30. Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D, Harris AL 1994 The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res Treat 29:41-49
31. Earp HS, Dawson TL, Li X, Yu H 1995 Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35:115-132
32. Arteaga CL, Coronado E, Osborne CK 1988 Blockade of the epidermal growth factor receptor inhibits transforming growth factor α-induced but not estrogen-induced growth of hormone-dependent human breast cancer. Mol Endocrinol 2:1064-1069
33. Ennis BW, Valverius EM, Bates SE, Lippman ME, Bellot F, Kris R, Schlessinger J, Masui H, Goldenberg A, Mendelsohn J, Dickson RB 1989 Antiepidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol Endocrinol 3:1830-1838
34. Baselga J, Mendelsohn J 1994 The epidermal growth factor receptor as a target for therapy in breast cancer. Breast Cancer Res Treat 29:127-138
35. Ciardello F, Damiano V, Bianco C, di Isernia G, Ruggiero A, Caraglia M Tagliaferri P, Baselga J, Mendelsohn J, Bianco AR, Tortora G 1995 Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. Clin Cancer Res 1:161-167
36. Shankar V, Ciardiello F, Kim N, Derynck R, Liscia DS, Merlo G, Langton B, Sheer D, Callahan R, Bassin R, Lippman R, Hynes NE, Salomon DS 1989 Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA. Mol Carcinog 2:1-11
37. Sandgren EP, Luetteke NC, Palmiter R, Brinster R, Lee DC 1990 Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia and carcinoma of the breast. Cell 61:1121-1135
38. Sundaresan S, Colin IM, Pestell RG, Jameson JL 1996 Stimulation of mitogen-activated protein kinase by gonadotropin releasing hormone: evidence for involvement of protein kinase C. Endocrinology 137:304-311
39. Kay TWH, Jameson JL 1992 Identification of a gonadotropin-releasing hormone-responsive region in the glycoprotein hormone α-subunit promoter. Mol Endocrinol 6:1767-1773
40. Marais R, Wynne J, Treisman R 1993 The SRF accessory protein lk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393
41. Chen C, Okayama H 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
42. Lowe Jr WL, Teasdale RM 1992 Characterization of a rat insulin-like growth factor I gene promoter. Biochem Biophys Res Commun 189:972-978
43. An MR, Lowe Jr WL 1995 The major promoter of the rat insulin-like growth factor-I gene binds a protein complex that is required for basal expression. Mol Cell Endocrinol 114:77-89
44. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-272
45. Fabian JR, Morrison DK, Daar IO 1993 Requirement for Raf and MAP kinase function during the meiotic maturation of Xenopus oocytes. J Cell Biol 122:645-652
46. Hipskind RA, Nordheim A 1991 Functional dissection in vitro of the human c-fos promoter. J Biol Chem 266:19583-19592
47. Treisman R 1992 The serum response element. Trends Biol Sci 17:423-426
48. Johansen F-E, Prywes R 1995 Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochim Biophys Acta 1242:1-10
49. Deutsch PJ, Jameson JL, Habener JF 1987 Cyclic AMP responsiveness of human gonadotropin-alpha gene transcription is directed by a repeated 18-base pair enhancer. Alpha-promoter receptivity to the enhancer confers cell-preferential expression. J Biol Chem 262:12169-12174
50. Vittet D, Duperay C, Chevillard C 1995 Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell line. J Cell Physiol 163:645-655
51. Lowe Jr WL 1991 Biological actions of the insulin-like growth factors. In: LeRoith D (ed) Insulin-Like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton, pp 49-85
52. Hipskind RA, Buscher D, Nordheim A, Baccarini M 1994 Ras/ MAP kinase-dependent and - independent signaling pathways target distinct ternary complex factors. Genes Dev 8:1803-1816
53. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ 1995 Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407
54. Zinck R, Cahill MA, Kracht M, Sachsenmaier C, Hipskind RA, Nordheim A 1995 Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol Cell Biol 15:4930-4938
55. Webster J, Prager D, Melmed S 1994 Insulin-like growth factor-1 activation of extracellular signal related kinase-1 and -2 in growth hormone-secreting cells. Mol Endocrinol 8:539-544
56. Frodin M, Peraldi P, van Obberghen E 1994 Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269:6207-6214
57. Erhardt P, Troppmair J, Rapp UR, Cooper GM 1995 Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol 15:5524-5530
58. Hazlerigg DG, Thompson M, Hastings MH, Morgan PJ 1996 Regulation of mitogen-activated protein kinase in the pars tuberalis of the ovine pituitary: interactions between melatonin, insulin-like growth factor-1, and forskolin. Endocrinology 137:210-218
59. McKenzie FR, Pouyssegur J 1996 cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition, cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J Biol Chem 271:13476-13483
60. Hsueh Y-P, Lai M-Z 1995 c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J Biol Chem 270:18094-18098
61. Rao GN, Runge MS 1996 Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. J Biol Chem 271:20805-20810